CTKB: Cytek Corp Amount of Cash per Share

Cytek Biosciences, Inc. - graphic logo of issuer CTKB

This daily price chart of cash per share on GURU.Markets reflects current liquidity, where the value 1.95 describes the level of financial reserves. Cytek Biosciences, Inc. (CTKB) is implementing energy-efficient analyzers to reduce chemical waste. Stable FCF is driven by the sale of consumables for cytometers. High demand for IT services in immunology offsets the risks associated with the narrow specialization of the equipment.

CTKB - Cytek Bio Cash per Share over the range 07/04/2022 - 11/20/2026

Analytical breakdowns for Cytek Biosciences, Inc.

- cash availability and cash flow indicators:
Summary company analysis:CTKB Cytek Bio
Original product of Cytek Biosciences

The development of flow cytometry systems and the implementation of FSP technology require significant capital expenditures in R&D and expansion into biopharmaceutical markets. Calculating this indicator by dividing total liquidity by the number of shares determines the actual size of the cash cushion, which allows for a real-time assessment of Cytek Biosciences, Inc. (CTKB) resilience to risks and the efficiency of its free capital management based on the current cash per share level.